Skip to content

OptiChamber Advantage Anti-Static Valved Holding Chamber

by Respironics New Jersey, Inc. 510(k)

Active United States

510(k) K072418

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK072418 Date12 Sep 2007ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
CAF
Device Class
Class II
Regulation
21 CFR Part 868.5630
Advisory Committee
Anesthesiology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 23 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The OptiChamber Advantage Anti-Static Valved Holding Chamber is a spacer device intended to be used in combination with Metered Dose Inhalers (MDIs) for respiratory drug delivery. It is designed to leave larger non-respirable drug particles within the device while allowing smaller respirable particles to be delivered to the lungs.

The device is supplied as a reusable holding chamber and is indicated for use in respiratory therapy settings. It has received FDA 510(k) clearance under K072418 and is classified under product code CAF. No claims regarding sterility, single-use status, MRI safety, sizes, storage conditions, or additional authorisations are present in the provided data.

Other devices from Respironics New Jersey, Inc.

Questions

AI-generated answers, 23 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the OptiChamber Advantage Anti-Static Valved Holding Chamber used for?

    It is intended to be used in combination with Metered Dose Inhalers (MDIs) for respiratory drug delivery, designed to leave larger non-respirable drug particles within the device while allowing smaller respirable particles to reach the lungs.

  • Is the OptiChamber Advantage Anti-Static Valved Holding Chamber reusable or single-use?

    The device is supplied as a reusable holding chamber, as stated in the description, and is indicated for use in respiratory therapy settings, meaning it is intended for multiple uses after proper cleaning.

  • Does the OptiChamber Advantage Anti-Static Valved Holding Chamber come in different sizes or models?

    The provided data does not specify any sizes, models, or reference numbers beyond the device name, so no variations in size or model are indicated in the available information.

  • Is the OptiChamber Advantage Anti-Static Valved Holding Chamber sterile when supplied?

    No claims regarding sterility are present in the provided data, so the device is not indicated as sterile upon supply and should be cleaned according to manufacturer instructions before use.

  • What regulatory pathway was used for the OptiChamber Advantage Anti-Static Valved Holding Chamber?

    The device received FDA 510(k) clearance under submission number K072418, as explicitly stated in the AUTHORIZATIONS and SPECIFICATIONS sections, confirming its regulatory route as a traditional 510(k) submission.